US Stock MarketDetailed Quotes

ARMP Armata Pharmaceuticals

Watchlist

3.091
-0.169-5.18%

Close May 10 16:00 ET

3.150
+0.059+1.90%

Post 16:57 ET

111.76MMarket Cap-1405P/E (TTM)

Armata Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

39.76%-10.58M

-46.00%-47.42M

22.69%-8.11M

6.25%-9.69M

-48.01%-12.06M

-399.86%-17.57M

-37.78%-32.48M

-21.95%-10.49M

-108.16%-10.33M

-79.55%-8.15M

Net income from continuing operations

-72.68%-25.02M

-87.03%-69.05M

-92.43%-19.85M

-261.75%-31.16M

61.51%-3.55M

-65.15%-14.49M

-59.43%-36.92M

-70.56%-10.31M

-58.96%-8.61M

-48.77%-9.22M

Operating gains losses

----

--3.94M

--81K

----

Depreciation and amortization

37.83%317K

8.97%972K

19.59%293K

-2.21%221K

16.92%228K

1.77%230K

-23.70%892K

-11.55%245K

-28.03%226K

-34.34%195K

Other non cash items

383.18%15.28M

--25.41M

--10.62M

--17.67M

---6.04M

--3.16M

----

Change In working capital

76.91%-1.69M

-2,297.27%-9.65M

3,194.44%557K

102.30%92K

-3,751.95%-2.97M

-261.43%-7.33M

113.62%439K

99.48%-18K

-1,111.62%-4.01M

-117.04%-77K

-Change in prepaid assets

226.73%1.8M

162.99%4.83M

192.28%4.9M

176.44%2.14M

-177.82%-789K

-296.13%-1.42M

-292.92%-7.66M

-209.87%-5.31M

-2,215.91%-2.79M

26.04%-284K

-Change in payables and accrued expense

41.79%-1.31M

-122.90%-1.02M

-119.75%-613K

123.17%206K

52.76%1.63M

-291.40%-2.25M

579.57%4.46M

885.82%3.1M

-397.32%-889K

28.64%1.07M

-Change in other current liabilities

40.47%-2.18M

-469.23%-13.45M

-270.54%-3.73M

----

---3.66M

--3.64M

--2.19M

----

-Change in other working capital

----

1,756.25%891K

Cash from discontinued investing activities

Operating cash flow

39.76%-10.58M

-46.00%-47.42M

22.69%-8.11M

6.25%-9.69M

-48.01%-12.06M

-399.86%-17.57M

-37.78%-32.48M

-21.95%-10.49M

-108.16%-10.33M

-79.55%-8.15M

Investing cash flow

Cash flow from continuing investing activities

87.56%-250K

-267.89%-8.13M

-625.27%-2.39M

-171.41%-3.51M

80.46%-222K

-751.69%-2.01M

-69.56%-2.21M

299.56%455K

-122.34%-1.29M

-479.59%-1.14M

Net PPE purchase and sale

87.56%-250K

-267.89%-8.13M

-625.27%-2.39M

-171.41%-3.51M

80.46%-222K

-751.69%-2.01M

-69.56%-2.21M

299.56%455K

-122.34%-1.29M

-479.59%-1.14M

Cash from discontinued investing activities

Investing cash flow

87.56%-250K

-267.89%-8.13M

-625.27%-2.39M

-171.41%-3.51M

80.46%-222K

-751.69%-2.01M

-69.56%-2.21M

299.56%455K

-122.34%-1.29M

-479.59%-1.14M

Financing cash flow

Cash flow from continuing financing activities

18.03%34.93M

22.66%53.99M

91.40%-43K

79,916.13%24.81M

-152.05%-368K

-33.69%29.59M

72.49%44.02M

-107.10%-500K

-63.95%31K

21.08%-146K

Net issuance payments of debt

17.89%34.89M

--54.03M

--0

--24.8M

---368K

--29.59M

--0

Net common stock issuance

----

--0

----

68.67%44.39M

--0

---23K

-17.30%-217K

Proceeds from stock option exercised by employees

--42K

-96.00%5K

--0

-90.74%5K

--0

-79.61%125K

--0

-37.21%54K

----

Net other financing activities

----

91.40%-43K

----

64.64%-500K

----

Cash from discontinued financing activities

Financing cash flow

18.03%34.93M

22.66%53.99M

91.40%-43K

79,916.13%24.81M

-152.05%-368K

-33.69%29.59M

72.49%44.02M

-107.10%-500K

-63.95%31K

21.08%-146K

Net cash flow

Beginning cash position

-7.54%19.24M

81.16%20.81M

-4.98%29.78M

-57.67%18.18M

-41.14%30.83M

81.16%20.81M

5.89%11.49M

136.08%31.34M

129.17%42.94M

121.38%52.37M

Current changes in cash

140.63%24.1M

-116.83%-1.57M

-0.09%-10.54M

200.09%11.61M

-34.15%-12.65M

-75.50%10.01M

1,359.15%9.32M

-488.93%-10.53M

-112.38%-11.6M

-91.71%-9.43M

End cash Position

40.60%43.34M

-7.54%19.24M

-4.98%29.78M

-57.67%18.18M

-41.14%30.83M

81.16%20.81M

136.08%31.34M

129.17%42.94M

Free cash flow

44.67%-10.83M

-60.17%-55.57M

-4.75%-10.51M

-13.52%-13.2M

-32.29%-12.28M

-421.99%-19.58M

-39.44%-34.69M

-13.64%-10.03M

-109.65%-11.63M

-96.11%-9.28M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	39.76%-10.58M	-46.00%-47.42M	22.69%-8.11M	6.25%-9.69M	-48.01%-12.06M	-399.86%-17.57M	-37.78%-32.48M	-21.95%-10.49M	-108.16%-10.33M	-79.55%-8.15M
Net income from continuing operations	-72.68%-25.02M	-87.03%-69.05M	-92.43%-19.85M	-261.75%-31.16M	61.51%-3.55M	-65.15%-14.49M	-59.43%-36.92M	-70.56%-10.31M	-58.96%-8.61M	-48.77%-9.22M
Operating gains losses	----	--3.94M	--81K	----	----	----	----	----	----	----
Depreciation and amortization	37.83%317K	8.97%972K	19.59%293K	-2.21%221K	16.92%228K	1.77%230K	-23.70%892K	-11.55%245K	-28.03%226K	-34.34%195K
Other non cash items	383.18%15.28M	--25.41M	--10.62M	--17.67M	---6.04M	--3.16M	----	----	----	----
Change In working capital	76.91%-1.69M	-2,297.27%-9.65M	3,194.44%557K	102.30%92K	-3,751.95%-2.97M	-261.43%-7.33M	113.62%439K	99.48%-18K	-1,111.62%-4.01M	-117.04%-77K
-Change in prepaid assets	226.73%1.8M	162.99%4.83M	192.28%4.9M	176.44%2.14M	-177.82%-789K	-296.13%-1.42M	-292.92%-7.66M	-209.87%-5.31M	-2,215.91%-2.79M	26.04%-284K
-Change in payables and accrued expense	41.79%-1.31M	-122.90%-1.02M	-119.75%-613K	123.17%206K	52.76%1.63M	-291.40%-2.25M	579.57%4.46M	885.82%3.1M	-397.32%-889K	28.64%1.07M
-Change in other current liabilities	40.47%-2.18M	-469.23%-13.45M	-270.54%-3.73M	----	----	---3.66M	--3.64M	--2.19M	----	----
-Change in other working capital	----	----	----	----	----	----	----	----	----	1,756.25%891K
Cash from discontinued investing activities
Operating cash flow	39.76%-10.58M	-46.00%-47.42M	22.69%-8.11M	6.25%-9.69M	-48.01%-12.06M	-399.86%-17.57M	-37.78%-32.48M	-21.95%-10.49M	-108.16%-10.33M	-79.55%-8.15M
Investing cash flow
Cash flow from continuing investing activities	87.56%-250K	-267.89%-8.13M	-625.27%-2.39M	-171.41%-3.51M	80.46%-222K	-751.69%-2.01M	-69.56%-2.21M	299.56%455K	-122.34%-1.29M	-479.59%-1.14M
Net PPE purchase and sale	87.56%-250K	-267.89%-8.13M	-625.27%-2.39M	-171.41%-3.51M	80.46%-222K	-751.69%-2.01M	-69.56%-2.21M	299.56%455K	-122.34%-1.29M	-479.59%-1.14M
Cash from discontinued investing activities
Investing cash flow	87.56%-250K	-267.89%-8.13M	-625.27%-2.39M	-171.41%-3.51M	80.46%-222K	-751.69%-2.01M	-69.56%-2.21M	299.56%455K	-122.34%-1.29M	-479.59%-1.14M
Financing cash flow
Cash flow from continuing financing activities	18.03%34.93M	22.66%53.99M	91.40%-43K	79,916.13%24.81M	-152.05%-368K	-33.69%29.59M	72.49%44.02M	-107.10%-500K	-63.95%31K	21.08%-146K
Net issuance payments of debt	17.89%34.89M	--54.03M	--0	--24.8M	---368K	--29.59M	--0	--0	--0	--0
Net common stock issuance	----	--0	--0	--0	----	----	68.67%44.39M	--0	---23K	-17.30%-217K
Proceeds from stock option exercised by employees	--42K	-96.00%5K	--0	-90.74%5K	--0	--0	-79.61%125K	--0	-37.21%54K	----
Net other financing activities	----	91.40%-43K	----	----	----	----	64.64%-500K	----	----	----
Cash from discontinued financing activities
Financing cash flow	18.03%34.93M	22.66%53.99M	91.40%-43K	79,916.13%24.81M	-152.05%-368K	-33.69%29.59M	72.49%44.02M	-107.10%-500K	-63.95%31K	21.08%-146K
Net cash flow
Beginning cash position	-7.54%19.24M	81.16%20.81M	-4.98%29.78M	-57.67%18.18M	-41.14%30.83M	81.16%20.81M	5.89%11.49M	136.08%31.34M	129.17%42.94M	121.38%52.37M
Current changes in cash	140.63%24.1M	-116.83%-1.57M	-0.09%-10.54M	200.09%11.61M	-34.15%-12.65M	-75.50%10.01M	1,359.15%9.32M	-488.93%-10.53M	-112.38%-11.6M	-91.71%-9.43M
End cash Position	40.60%43.34M	-7.54%19.24M	-7.54%19.24M	-4.98%29.78M	-57.67%18.18M	-41.14%30.83M	81.16%20.81M	81.16%20.81M	136.08%31.34M	129.17%42.94M
Free cash flow	44.67%-10.83M	-60.17%-55.57M	-4.75%-10.51M	-13.52%-13.2M	-32.29%-12.28M	-421.99%-19.58M	-39.44%-34.69M	-13.64%-10.03M	-109.65%-11.63M	-96.11%-9.28M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall